Home ›
Trademark Categories ›
Pharmaceuticals ›
2008 ›
AR ›
ARMENBE
Trademark search for:
ARMENBE
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2008-07-18 — Application filed
2008-09-11 — Sn assigned for sect 66a appl from ib
2008-09-12 — Application filed
2008-10-19 — Assigned to examiner
2008-10-25 — Final disposition recorded
2008-10-26 — Office action issued
2008-10-27 — Office action issued
2008-10-27 — Office action issued
2008-11-14 — Teas change of correspondence received
2008-11-14 — Office action issued
2008-11-21 — Office action issued
2008-11-25 — Approved for pub - principal register
2008-11-25 — Teas/email correspondence entered
2008-11-25 — Assigned to lie
2008-11-25 — Correspondence received in law office
2008-11-25 — Law office publication review completed
2008-12-10 — Notice of publication
2008-12-30 — Published for opposition
2009-03-17 — Registered-principal register
2009-03-26 — New representative at ib received
2009-04-24 — Teas change of correspondence received
2009-06-18 — Final disposition recorded
2009-07-06 — Final disposition recorded
2009-07-06 — Final disposition recorded
2009-10-02 — Final disposition recorded
2013-04-28 — New representative at ib received
2015-07-03 — Change of owner received from ib
2015-10-23 — Cancelled section 71
2016-06-23 — Total invalidation of reg ext protection created
2016-06-23 — Total invalidation of reg ext protection sent to ib
2016-06-23 — Invalidation processed
2017-04-14 — Total invalidation processed by the ib
2018-07-19 — Final status recorded
2019-02-08 — Death of international registration
2019-02-08 — Notification of effect of cancellation of intl reg mailed
Owner Information
Glaxosmithkline Biologicals S.A.
Novartis AG
Novartis AG
Novartis AG
Correspondent
Nancy Sabarra Fross Zelnick Lehrman & Zissu, P.C.
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
